The gut microbiota is emerging as a promising target for the management or prevention of inflammatory and metabolic disorders in humans. Many of the current research efforts are focused on the identification of specific ...

In few months, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has become the main health worldwide problem. Epidemiological studies revealed that population has different vulnerability to SARS-CoV-2: ...

Dysbiosis observed in autoimmune diseases is associated with decreased bacteria function and diversity, impaired epithelial barrier, bacterial translocation, inflammation, and decreased regulatory T cells (Tregs) in the ...

Purpose of reviewThe gut microbiome is critical for human health, and its alteration is associated with intestinal, autoimmune and metabolic diseases. Numerous studies have focused on prevention or treatment of dysbiotic ...

Gastrointestinal (GI) involvement is an early manifestation in systemic sclerosis (SSc), affecting more than 90% of patients, and severe GI disease is a marker of poor prognosis and mortality. Recent studies have hypothesized ...